Arijit Dasgupta

Summary

Affiliation: University of Kentucky
Country: USA

Publications

  1. doi Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] tri
    Arijit Dasgupta
    Gill Heart Institute, University of Kentucky, Lexington, Kentucky, USA
    Am J Cardiol 103:1359-63. 2009
  2. pmc Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary intervention
    Arijit Dasgupta
    Gill Heart Institute, University of Kentucky, Lexington, KY 40536 0200, USA
    Vasc Health Risk Manag 5:275-86. 2009

Detail Information

Publications2

  1. doi Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] tri
    Arijit Dasgupta
    Gill Heart Institute, University of Kentucky, Lexington, Kentucky, USA
    Am J Cardiol 103:1359-63. 2009
    ..In conclusion, this post hoc analysis suggested that clopidogrel may be harmful in patients with diabetic nephropathy. Additional studies are needed to investigate this possible interaction...
  2. pmc Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary intervention
    Arijit Dasgupta
    Gill Heart Institute, University of Kentucky, Lexington, KY 40536 0200, USA
    Vasc Health Risk Manag 5:275-86. 2009
    ..The benefit obtained from clopidogrel appears independent of and incremental to that of other antiplatelet and antithrombotic agents used during and after coronary intervention...